Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Aug;31(8):4837-4838.
doi: 10.1245/s10434-024-15323-8. Epub 2024 May 2.

Defining and Refining the Role of Adjuvant Chemoradiation for Biliary Tract Cancers After SWOG 0809

Belkacem Acidi  1 , Hop S Tran Cao  2
Affiliations
Editorial

Defining and Refining the Role of Adjuvant Chemoradiation for Biliary Tract Cancers After SWOG 0809

Belkacem Acidi et al. Ann Surg Oncol. 2024 Aug.
No abstract available

PubMed Disclaimer

References

    1. Dominguez D, Wong P, Chen YJ, et al. Adjuvant chemoradiation in resected biliary adenocarcinoma: evaluation of SWOG S0809 with a large national database. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15117-y . - DOI - PubMed
    1. Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, Zalupski MM, Lowy AM, et al. SWOG S0809: A phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015;33(24):2617–22. - DOI - PubMed
    1. Ahn DH, Bekaii-Saab T. Biliary cancer: intrahepatic cholangiocarcinoma versus extrahepatic cholangiocarcinoma versus gallbladder cancers: classification and therapeutic implications. J Gastrointest Oncol. 2017;8(2):293–301. - DOI - PubMed - PMC
    1. Oh DY, Lee KH, Lee DW, Yoon J, Kim TY, Bang JH, et al. Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study. Lancet Gastroenterol Hepatol. 2022;7(6):522–32. - DOI - PubMed
    1. Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401(10391):1853–65. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources